Blog

7 October 2020 - From 19 October 2020, developers of human or veterinary medicines should use EMA’s IRIS Regulatory & ...

23 June 2020 - To further encourage the development of treatments for rare diseases, EMA will waive all fees for ...

13 March 2020 - EMA provides full fee waivers for scientific advice applications from developers of potential therapeutics (to treat ...

1 March 2019 - CADTH is pleased to announce a new collaboration with Health Canada and the Institut national d'excellence en ...

14 February 2019 - The NICE Scientific Advice team, working with the Science Policy and Research team at NICE, has provided ...

6 February 2019 - NICE and the Canadian Agency for Drugs and Technology in Health have launched a new collaboration to ...

6 February 2019 - CADTH is pleased to announce a new collaboration with England’s NICE (National Institute for Health and ...

29 January 2019 - NICE has announced a collaboration with the body which represents life sciences organisations in the UK. ...

7 June 2018 - NICE Scientific Advice (NSA) launched a new health economic model review service, PRIMA, in December 2017 and ...

19 February 2018 - Optional scientific advice for the early benefit assessment of pharmaceuticals is offered by the German decision maker, ...

6 October 2015 - The Management Board heard an update on the European Medicines Agency’s (EMA) activities in the first half ...